PLUS THERAPEUTICS INC (PSTV) Fundamental Analysis & Valuation

NASDAQ:PSTV • US72941H5090

Current stock price

3.92 USD
+0.75 (+23.66%)
At close:
4.23 USD
+0.31 (+7.91%)
Pre-Market:

This PSTV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. PSTV Profitability Analysis

1.1 Basic Checks

  • PSTV had negative earnings in the past year.
  • PSTV had a negative operating cash flow in the past year.
  • PSTV had negative earnings in each of the past 5 years.
  • In the past 5 years PSTV always reported negative operating cash flow.
PSTV Yearly Net Income VS EBIT VS OCF VS FCFPSTV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M -25M

1.2 Ratios

  • PSTV has a worse Return On Assets (-137.13%) than 81.82% of its industry peers.
  • With a Return On Equity value of -560.21%, PSTV is not doing good in the industry: 77.56% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -137.13%
ROE -560.21%
ROIC N/A
ROA(3y)-149.9%
ROA(5y)-119.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PSTV Yearly ROA, ROE, ROICPSTV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PSTV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PSTV Yearly Profit, Operating, Gross MarginsPSTV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. PSTV Health Analysis

2.1 Basic Checks

  • PSTV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for PSTV has been increased compared to 1 year ago.
  • Compared to 5 years ago, PSTV has more shares outstanding
  • The debt/assets ratio for PSTV has been reduced compared to a year ago.
PSTV Yearly Shares OutstandingPSTV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
PSTV Yearly Total Debt VS Total AssetsPSTV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -14.08, we must say that PSTV is in the distress zone and has some risk of bankruptcy.
  • PSTV has a Altman-Z score of -14.08. This is in the lower half of the industry: PSTV underperforms 79.69% of its industry peers.
  • A Debt/Equity ratio of 0.19 indicates that PSTV is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.19, PSTV is not doing good in the industry: 65.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z -14.08
ROIC/WACCN/A
WACC9.17%
PSTV Yearly LT Debt VS Equity VS FCFPSTV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M -20M

2.3 Liquidity

  • PSTV has a Current Ratio of 1.23. This is a normal value and indicates that PSTV is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.23, PSTV is not doing good in the industry: 84.14% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.23 indicates that PSTV should not have too much problems paying its short term obligations.
  • PSTV has a worse Quick ratio (1.23) than 83.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
PSTV Yearly Current Assets VS Current LiabilitesPSTV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. PSTV Growth Analysis

3.1 Past

  • The earnings per share for PSTV have decreased strongly by -47.80% in the last year.
  • The Revenue for PSTV has decreased by -10.49% in the past year. This is quite bad
  • Measured over the past years, PSTV shows a very strong growth in Revenue. The Revenue has been growing by 77.01% on average per year.
EPS 1Y (TTM)-47.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-111.68%
Revenue 1Y (TTM)-10.49%
Revenue growth 3Y187.23%
Revenue growth 5Y77.01%
Sales Q2Q%-3.19%

3.2 Future

  • Based on estimates for the next years, PSTV will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.09% on average per year.
  • PSTV is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 103.16% yearly.
EPS Next Y94.67%
EPS Next 2Y40.38%
EPS Next 3Y25.66%
EPS Next 5Y16.09%
Revenue Next Year17.05%
Revenue Next 2Y110.73%
Revenue Next 3Y107.75%
Revenue Next 5Y103.16%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PSTV Yearly Revenue VS EstimatesPSTV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
PSTV Yearly EPS VS EstimatesPSTV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -200K -400K -600K -800K -1M

More info and screens

Find the best growth stocksShow best growing peers

1

4. PSTV Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PSTV. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PSTV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PSTV Price Earnings VS Forward Price EarningsPSTV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSTV Per share dataPSTV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

  • PSTV's earnings are expected to grow with 25.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.38%
EPS Next 3Y25.66%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PSTV Dividend Analysis

5.1 Amount

  • PSTV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PSTV Fundamentals: All Metrics, Ratios and Statistics

PLUS THERAPEUTICS INC

NASDAQ:PSTV (4/9/2026, 8:00:02 PM)

Premarket: 4.23 +0.31 (+7.91%)

3.92

+0.75 (+23.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-12
Earnings (Next)05-28
Inst Owners12.99%
Inst Owner Change0%
Ins Owners0.34%
Ins Owner Change22.04%
Market Cap672.48M
Revenue(TTM)5.21M
Net Income(TTM)-22.39M
Analysts80
Price TargetN/A
Short Float %11.87%
Short Ratio2.42
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-60.62%
Min EPS beat(2)-96.08%
Max EPS beat(2)-25.16%
EPS beat(4)1
Avg EPS beat(4)-173.72%
Min EPS beat(4)-695.44%
Max EPS beat(4)121.79%
EPS beat(8)4
Avg EPS beat(8)-78.39%
EPS beat(12)7
Avg EPS beat(12)-44.15%
EPS beat(16)9
Avg EPS beat(16)-31.88%
Revenue beat(2)1
Avg Revenue beat(2)-2.21%
Min Revenue beat(2)-8.69%
Max Revenue beat(2)4.27%
Revenue beat(4)1
Avg Revenue beat(4)-10.68%
Min Revenue beat(4)-30.01%
Max Revenue beat(4)4.27%
Revenue beat(8)2
Avg Revenue beat(8)-4.86%
Revenue beat(12)4
Avg Revenue beat(12)6.15%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.39%
PT rev (3m)-26.45%
EPS NQ rev (1m)-2525.26%
EPS NQ rev (3m)-2087.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-16.86%
Revenue NQ rev (1m)-29.66%
Revenue NQ rev (3m)-36.58%
Revenue NY rev (1m)-19.99%
Revenue NY rev (3m)-4.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 129
P/FCF N/A
P/OCF N/A
P/B 168.29
P/tB 204.34
EV/EBITDA N/A
EPS(TTM)-3.21
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0.03
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -137.13%
ROE -560.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-149.9%
ROA(5y)-119.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.06%
Cap/Sales 1.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z -14.08
F-Score4
WACC9.17%
ROIC/WACCN/A
Cap/Depr(3y)45.37%
Cap/Depr(5y)50.67%
Cap/Sales(3y)5.47%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-111.68%
EPS Next Y94.67%
EPS Next 2Y40.38%
EPS Next 3Y25.66%
EPS Next 5Y16.09%
Revenue 1Y (TTM)-10.49%
Revenue growth 3Y187.23%
Revenue growth 5Y77.01%
Sales Q2Q%-3.19%
Revenue Next Year17.05%
Revenue Next 2Y110.73%
Revenue Next 3Y107.75%
Revenue Next 5Y103.16%
EBIT growth 1Y-4.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2.26%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-85.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-96.84%
OCF growth 3YN/A
OCF growth 5YN/A

PLUS THERAPEUTICS INC / PSTV Fundamental Analysis FAQ

What is the fundamental rating for PSTV stock?

ChartMill assigns a fundamental rating of 2 / 10 to PSTV.


What is the valuation status of PLUS THERAPEUTICS INC (PSTV) stock?

ChartMill assigns a valuation rating of 1 / 10 to PLUS THERAPEUTICS INC (PSTV). This can be considered as Overvalued.


Can you provide the profitability details for PLUS THERAPEUTICS INC?

PLUS THERAPEUTICS INC (PSTV) has a profitability rating of 0 / 10.


How sustainable is the dividend of PLUS THERAPEUTICS INC (PSTV) stock?

The dividend rating of PLUS THERAPEUTICS INC (PSTV) is 0 / 10 and the dividend payout ratio is 0%.